| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2003 | EP0991644B1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 04/16/2003 | EP0988041B1 Use of dextran and other non-sulfated polysaccharides to improve mucus clearance |
| 04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
| 04/16/2003 | EP0972769B1 Novel amide derivatives and medicinal compositions thereof |
| 04/16/2003 | EP0971913B1 Process for the production of semi synthetic statins via novel intermediates |
| 04/16/2003 | EP0970083B1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION |
| 04/16/2003 | EP0961609B1 Methods for improving the health of hair and scalp |
| 04/16/2003 | EP0951465B1 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof |
| 04/16/2003 | EP0942896B1 Substituted phenols and thiophenols useful as antioxidant agents |
| 04/16/2003 | EP0927032B1 Buccal, non-polar spray for nitroglycerin |
| 04/16/2003 | EP0922045B1 Bicyclic pyrimidine derivatives and their use as anti-coagulants |
| 04/16/2003 | EP0912185B1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
| 04/16/2003 | EP0904055B1 Buccal, non-polar spray or capsule |
| 04/16/2003 | EP0893998B1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 04/16/2003 | EP0880508B1 Quinazoline derivatives as vegf inhibitors |
| 04/16/2003 | EP0873404B1 Angiotensin converting enzyme inhibitors |
| 04/16/2003 | EP0871632B1 Production of a crystalline salt of amoxicillin |
| 04/16/2003 | EP0869945B1 Catechol diethers derivatives useful as pharmaceutical agents |
| 04/16/2003 | EP0869803B1 Allogeneic paracrine cytokine tumor vaccines |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0800382B1 Use of compositions with benzoyl peroxide, glycolic acid and zinc for the treatment of dermatological disorders |
| 04/16/2003 | EP0792154B1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 04/16/2003 | EP0787724B1 Novel intermediate for production and process for producing pyridine derivative |
| 04/16/2003 | EP0782632B1 A method for identifying and using compounds that inactivate hiv-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| 04/16/2003 | EP0773955B1 New thrombin inhibitors, their preparation and use |
| 04/16/2003 | EP0765160B1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions |
| 04/16/2003 | EP0752838B1 Stable suppository formulations of delta-9-thc (tetrahydrocannabinol) |
| 04/16/2003 | EP0737069B1 Deuterised active agents in transdermal application |
| 04/16/2003 | EP0734252B1 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 04/16/2003 | EP0680338B1 Ganglioside-klh conjugate vaccines with qs-21 |
| 04/16/2003 | EP0674634B1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | EP0648271B1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/16/2003 | CN1411508A Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 04/16/2003 | CN1411466A Compound (I), method for extracting it and pharmaceutical composition containing it |
| 04/16/2003 | CN1411461A Thienopyridine derivatives and their preparing process and use |
| 04/16/2003 | CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 04/16/2003 | CN1411459A Compound and method for treatment of pain |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411457A Substituted pyrroles |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/16/2003 | CN1411454A Method for preparation of citalopram |
| 04/16/2003 | CN1411453A Trans olefinic glucokinase activators |
| 04/16/2003 | CN1411450A Method for production of triazolinethione derivative |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411442A Farnesyl transferase inhibitors |
| 04/16/2003 | CN1411441A Farnesyl protein transferase inhibitors |
| 04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 04/16/2003 | CN1411436A Hydroxamic acid derivative as inhibitor of formation of soluble human CD23 |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1411388A Methods for extraction and reaction using supercritical fluids |
| 04/16/2003 | CN1411386A Treatment of subnormal bone mineral density |
| 04/16/2003 | CN1411380A Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 04/16/2003 | CN1411379A Preventives or remedies for arrhythmia |
| 04/16/2003 | CN1411376A Novel helicobacter pylori-binding substances and use thereof |
| 04/16/2003 | CN1411375A Use of bioactive metabolites of gepirone for treatment of psychological disorders |
| 04/16/2003 | CN1411374A Substituted piperazine and piperidine calcium channel blockers |
| 04/16/2003 | CN1411373A Novel processes for making-and new crystalline form of-leflunomide |
| 04/16/2003 | CN1411372A Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/16/2003 | CN1411368A Method for producing liposome preparation |
| 04/16/2003 | CN1411367A Suspension comprising oxcarbazepine |
| 04/16/2003 | CN1411347A Composition for improving proliferative response during adapation of gastrointestinal tract and use in short bowel syndrome |
| 04/16/2003 | CN1411341A Reduced calorie fat compositions |
| 04/16/2003 | CN1411339A Antimicrobial composition comprising benzoic acid analog and metal salt |
| 04/16/2003 | CN1411337A Anthelmintic compositions |
| 04/16/2003 | CN1410421A Intermediate for preparing 10-deacetylation baccatin III and 10-deacetylation-14 beta hydroxy baccatin III derivatives |
| 04/16/2003 | CN1410419A Method and composition for treating or preventing bacterial infection |
| 04/16/2003 | CN1410413A Naprosyn precusor, its synthesis method and application |
| 04/16/2003 | CN1410122A Chinese medicine preparation for treating acute condyloma |
| 04/16/2003 | CN1410121A Medicine for treating archosyrinx and its preparation method |
| 04/16/2003 | CN1410112A Fuyuan plaster for promoting blood circulation |
| 04/16/2003 | CN1410106A Xiatare ointment and its preparation method |
| 04/16/2003 | CN1410094A Ointment for treating nuchal rigidity |
| 04/16/2003 | CN1410081A Capsule for treating rheumatism, rheumatoid archritis |
| 04/16/2003 | CN1410078A Medicine for treating stomach disease and its preparation method |
| 04/16/2003 | CN1410075A Application of fur seal oil in preparation of medicine for treating lipometabolism disorder (high blood fat) |
| 04/16/2003 | CN1410072A Sulfadiazine silver chitinamine powder |
| 04/16/2003 | CN1410071A Archimycin gel for eye application |
| 04/16/2003 | CN1410070A Acne cream |
| 04/16/2003 | CN1410069A Broad spectrum anti bacterial traditional Chinese medicine and its preparation method |
| 04/16/2003 | CN1410068A Preparation method of water soluble tanshinone |
| 04/16/2003 | CN1410067A Chloromycetin kibe ointment |
| 04/16/2003 | CN1410066A Ursolic acid poly lactic acid nano particle freeze dried powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410065A Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410064A Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method |
| 04/16/2003 | CN1410063A Embedding agent for long acting blood pressure reducing |
| 04/16/2003 | CN1410062A Sodium rebeilazole for injection use |
| 04/16/2003 | CN1410061A Nimudipin undertongue spraying agent |
| 04/16/2003 | CN1410060A 苦参碱阴道凝胶 Matrine vaginal gel |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/16/2003 | CN1410058A Application of difenitriazole in preparation of medicine for treating malignant tumour |
| 04/16/2003 | CN1410057A Special inhibitor for ruminant urease |
| 04/16/2003 | CN1410056A Preparation method of water soluble anticancer medical microsphere |
| 04/16/2003 | CN1409995A Synthetic sweetener |
| 04/16/2003 | CN1105780C Method for preparing poly dispersed saccharide composition and resulting poly dispersed saccharide composition |